Browsing: 2026

Update July 10, 2026: Lupin Pharmaceuticals Inc. initiated a voluntary recall of 2.5 million bottles of prednisoLONE Acetate Ophthalmic Suspension, USP, 1%. The prescription eye drops are being recalled due to a “foreign substance.” You can see a full list of the recalled eye dropshere.  

Research and Innovation At SLEEP 2026, Miller School Scientists Showcase Sleep Research Driving Better Health Outcomes By: Chad Hanson | July 10, 2026 | 10 min. read | 

‹ Back to IndustriesHealthcareBy MarketScale Newsroom · July 5, 2026, 12:14 PM UTCDigital HealthAi WearablesTelehealthCms Share Learn this in 60 seconds

As blood sugar wellness and metabolic support remain major priorities for supplement shoppers in 2026, this Gluco Health review explores how the Simple Supplements formula is positioned for daily glucose metabolism support, what buyers should know about its seven disclosed ingredients, and why dosage transparency, lifestyle factors, and individual results matter before ordering

The Straits Times walked the CES show floor to highlight five digital health products that caught our eye, including an exoskeleton by Chinese company Dnsys

Wellbeing has become such a priceless (or in many cases pricey) endeavour that we can’t seem to get enough of it

Nine mental-health tips for a happier 2026 Move, play, sleep and anchor yourself in calm. Psychologist Valentina Ogaryan offers a guide for creating calm, centeredness and happiness in 2026.

As a new year approaches, fitness goals are once again being set, but the landscape of how people move, train and stay active is evolving

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE

Brown & Brown, trading at $60.83, is drawing attention for company culture as much as for its role in the insurance sector. The stock has risen 2.9% over the past week and 6.7% over the past month, while the longer term picture is mixed, with the share price up 17.7% over five years but down…